Clinical characteristics and outcome of childhood de novo acute myeloid leukemia in Saudi Arabia: A multicenter SAPHOS leukemia group study

被引:14
|
作者
Jastaniah, Wasil [1 ,2 ]
Al Ghemlas, Ibrahim [3 ,4 ]
Al Daama, Saad [5 ]
Ballourah, Walid [6 ]
Bayoumy, Mohammad [7 ]
Al-Anzi, Faisal [8 ]
Al Shareef, Omar [9 ]
Alsultan, Abdulrahman [10 ]
Abrar, Mohammed Burhan [2 ]
Al Sudairy, Reem [11 ]
机构
[1] Umm AlQura Univ, Fac Med, Dept Pediat, Mecca, Saudi Arabia
[2] King Abdul Aziz Med City, Princess Noorah Oncol Ctr, Jeddah, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia
[4] Alfaisal Univ, Fac Med, Riyadh, Saudi Arabia
[5] King Fahad Specialist Hosp, Dammam, Saudi Arabia
[6] King Fahad Med City, Riyadh, Saudi Arabia
[7] King Faisal Specialist Hosp & Res Ctr, Jeddah, Saudi Arabia
[8] Prince Faisal Bin Bandar Canc Ctr, Qaseem, Saudi Arabia
[9] Prince Sultan Mil Med City, Riyadh, Saudi Arabia
[10] King Saud Univ, Coll Med, Dept Pediat, Riyadh, Saudi Arabia
[11] King Abdul Aziz Med City, King Abdullah Specialized Childrens Hosp, Dept Pediat Hematol Oncol, Riyadh, Saudi Arabia
关键词
AML; Acute leukemia; Ethnic; Response; Risk; Developing; CHILDRENS-ONCOLOGY-GROUP; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; PEDIATRIC AML; CURRENT CONTROVERSIES; SUPPORTIVE CARE; CANCER-GROUP; TRIAL; RISK; ADOLESCENTS;
D O I
10.1016/j.leukres.2016.08.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Geographic variation and ethnicity have been implicated to influence the outcome of pediatric acute myeloid leukemia (AML). Furthermore, survival outcomes from developing countries are reported to be inferior to developed nations. We hypothesized that risk-and response-based outcome in high-income resource-rich developing countries would be comparable to developed nations as access to care and supportive measures would be similar. A total of 193 children diagnosed with de novo AML between January 2005 and December 2012 were identified, of those 175 were evaluable for outcome. Patients were stratified into low-risk (LR), intermediate-risk (IR), or high-risk (HR) groups. The complete remission (CR), early death, and induction failure rates were: 85.7%, 2.3%, and 12%; respectively. The 5-year cumulative incidences of relapse (CIR) and non-relapse mortality (NRM) were 43.1% and 9.8% respectively; overall survival (OS) was 58.8 +/- 4% and event-free survival (EFS) 40.9 +/- 4.1%. The 5-year OS for LR, IR, and HR groups were 72.0 +/- 6.9%, 59.8 +/- 6.2%, and 45.1 +/- 7.4%; respectively (p = 0.003); and EFS 50.5 +/- 8.0%, 46.3 +/- 6.4%, and 23.3 +/- 6.4%; respectively (p = 0.001). This study demonstrated comparable outcomes to those reported from developed countries. This suggests that utilization of risk-and response based protocols in developing countries can overcome ethnic and geographic variation, if access to care and supportive measures were similar. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 50 条
  • [1] Clinical characteristics and outcome of childhood acute promyelocitic leukemia (APL) in Saudi Arabia: a multicenter SAPHOS leukemia group study
    Jastaniah, Wasil
    Alsultan, Abdulrahman
    Al Daama, Saad
    Ballourah, Walid
    Bayoumy, Mohamed
    Al-Anzi, Faisal
    Al Shareef, Omar
    Abrar, Mohammed Burhan
    Al Sudairy, Reem
    Al Ghemlas, Ibrahim
    HEMATOLOGY, 2018, 23 (06) : 316 - 323
  • [2] Treatment results in children with myeloid leukemia of Down syndrome in Saudi Arabia: A multicenter SAPHOS leukemia group study
    Jastaniah, Wasil
    Alsultan, Abdulrahman
    Al Daama, Saad
    Ballourah, Walid
    Bayoumy, Mohammad
    Al-Anzi, Faisal
    Al Shareef, Omar
    Abrar, Mohammed Burhan
    Al Sudairy, Reem
    Al Ghemlas, Ibrahim
    LEUKEMIA RESEARCH, 2017, 58 : 48 - 54
  • [3] Identifying Prognostic Factors That Influence Outcome of Childhood Acute Myeloid Leukemia in First Relapse in Saudi Arabia: Results of the Multicenter SAPHOS Study
    Jastaniah, Wasil
    Bayoumy, Mohamed
    Alsultan, Abdulrahman
    Al Daama, Saad
    Ballourah, Walid
    Al-Anzi, Faisal
    Al Shareef, Omar
    Al Sudairy, Reem
    Abrar, Mohammed Burhan
    Al Ghemlas, Ibrahim
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (12): : 773 - 780
  • [4] Monosomal karyotype is not a predictor of dismal outcome in childhood de novo acute myeloid leukemia
    Lee, Na Hee
    Choi, Young Bae
    Yi, Eun-Sang
    Lee, Soo Hyun
    Kim, Hee-Jin
    Lee, Ji Won
    Sung, Ki Woong
    Koo, Hong Hoe
    Yoo, Keon Hee
    LEUKEMIA RESEARCH, 2016, 50 : 57 - 62
  • [5] BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics:: a Cancer and Leukemia Group B Study
    Baldus, CD
    Tanner, SM
    Ruppert, AS
    Whitman, SP
    Archer, KJ
    Marcucci, G
    Caligiuri, MA
    Carroll, AJ
    Vardiman, JW
    Powell, BL
    Allen, SL
    Moore, JO
    Larson, RA
    Kolitz, JE
    de la Chapelle, A
    Bloomfield, CD
    BLOOD, 2003, 102 (05) : 1613 - 1618
  • [6] A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia
    Luskin, Marlise R.
    Gimotty, Phyllis A.
    Smith, Catherine
    Loren, Alison W.
    Figueroa, Maria E.
    Harrison, Jenna
    Sun, Zhuoxin
    Tallman, Martin S.
    Paietta, Elisabeth M.
    Litzow, Mark R.
    Melnick, Ari M.
    Levine, Ross L.
    Fernandez, Hugo F.
    Luger, Selina M.
    Carroll, Martin
    Master, Stephen R.
    Wertheim, Gerald B. W.
    JCI INSIGHT, 2016, 1 (09)
  • [7] Flow cytometric analysis of de novo acute myeloid leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group
    Hideaki Ohta
    Shotaro Iwamoto
    Nobutaka Kiyokawa
    Masahito Tsurusawa
    Takao Deguchi
    Kozo Takase
    Junichiro Fujimoto
    Keizo Horibe
    Yoshihiro Komada
    International Journal of Hematology, 2011, 93 : 135 - 137
  • [8] Flow cytometric analysis of de novo acute myeloid leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group
    Ohta, Hideaki
    Iwamoto, Shotaro
    Kiyokawa, Nobutaka
    Tsurusawa, Masahito
    Deguchi, Takao
    Takase, Kozo
    Fujimoto, Junichiro
    Horibe, Keizo
    Komada, Yoshihiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (01) : 135 - 137
  • [9] Clinical challenges in de novo pediatric acute myeloid leukemia
    Klein, Kim
    de Haas, Valerie
    Kaspers, Gertjan J. L.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (03) : 277 - 293
  • [10] Clinical Characteristics and Treatment Outcome of Childhood Acute Lymphoblastic Leukemia in Saudi Arabia: A Multi-Institutional Retrospective National Collaborative Study
    Al-Sudairy, Reem
    Al-Nasser, Abdullah
    Alsultan, Abdulrahman
    Al Ahmari, Ali
    Abosoudah, Ibraheem
    Al-Hayek, Reema
    Al-Harbi, Talal
    Al-Manjomi, Fahad
    Al-Harbi, Musa
    Al-Ghamdi, Hasna
    Al-Shahrani, Mohammed
    Belgaumi, Asim F.
    PEDIATRIC BLOOD & CANCER, 2014, 61 (01) : 74 - 80